CTAD October 1 - 2023 Supporting materials Effects of Brexpiprazole on Agitation Associated With Dementia due to Alzheimer’s Disease: Analysis of Pooled Response Data From two Phase 3 Fixed-Dose Trials Effects of Brexpiprazole on Agitation Associated With Dementia due to Alzheimer’s Disease: Analysis of Pooled Efficacy Data From two Phase 3 Fixed-Dose Trials by Baseline Agitation Frequency A review of meaningful change in agitation behaviors associated with Alzheimer’s disease and the potential impact of brexpiprazole